Apigenin increases the neurotrophic activities of BDNF (brain-derived neurotrophic factor) through direct binding, which may serve as a possible treatment for its curative efficiency in neurodegenerative diseases and depression [89]. Here, BDNF is linked to depressive symptom measurement.